These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6542763)

  • 1. Clinical pharmacokinetics of aztreonam in cancer patients.
    Jones PG; Bodey GP; Swabb EA; Ho DH; Fainstein V; Pasternak J
    Antimicrob Agents Chemother; 1984 Oct; 26(4):455-61. PubMed ID: 6542763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of aztreonam in elderly male volunteers.
    Creasey WA; Platt TB; Frantz M; Sugerman AA
    Br J Clin Pharmacol; 1985 Feb; 19(2):233-7. PubMed ID: 4039189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of aztreonam in patients with chronic renal failure.
    Fillastre JP; Leroy A; Baudoin C; Humbert G; Swabb EA; Vertucci C; Godin M
    Clin Pharmacokinet; 1985; 10(1):91-100. PubMed ID: 4038635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review of single- and multiple-dose pharmacokinetics of the monobactam, aztreonam (SQ 26,776) in healthy subjects.
    Swabb EA; Sugerman AA
    Chemotherapy; 1983; 29(5):313-21. PubMed ID: 6684541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolism and pharmacokinetics of aztreonam in healthy subjects.
    Swabb EA; Singhvi SM; Leitz MA; Frantz M; Sugerman A
    Antimicrob Agents Chemother; 1983 Sep; 24(3):394-400. PubMed ID: 6685455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-dose pharmacokinetics of aztreonam in pediatric patients.
    Stutman HR; Marks MI; Swabb EA
    Antimicrob Agents Chemother; 1984 Aug; 26(2):196-9. PubMed ID: 6541452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple-dose pharmacokinetics of the monobactam azthreonam (SQ 26,776) in healthy subjects.
    Swabb EA; Sugerman AA; McKinstry DN
    Antimicrob Agents Chemother; 1983 Jan; 23(1):125-32. PubMed ID: 6681947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of aztreonam in patients with various degrees of renal dysfunction.
    Mihindu JC; Scheld WM; Bolton ND; Spyker DA; Swabb EA; Bolton WK
    Antimicrob Agents Chemother; 1983 Aug; 24(2):252-61. PubMed ID: 6685452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of aztreonam in patients with gram-negative infections.
    Janicke DM; Cafarell RF; Parker SW; Apicella MA; Jusko WJ
    Antimicrob Agents Chemother; 1985 Jan; 27(1):16-20. PubMed ID: 4039117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative pharmacokinetics of carumonam and aztreonam in mice, rats, rabbits, dogs, and cynomolgus monkeys.
    Kita Y; Fugono T; Imada A
    Antimicrob Agents Chemother; 1986 Jan; 29(1):127-34. PubMed ID: 3729325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of aztreonam in rabbit eyes.
    Barza M; McCue M
    Antimicrob Agents Chemother; 1983 Oct; 24(4):468-73. PubMed ID: 6685992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacology of aztreonam after intravenous infusion.
    Scully BE; Swabb EA; Neu HC
    Antimicrob Agents Chemother; 1983 Jul; 24(1):18-22. PubMed ID: 6684898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Penetration of aztreonam into human bronchial secretions.
    Bechard DL; Hawkins SS; Dhruv R; Friedhoff LT
    Antimicrob Agents Chemother; 1985 Feb; 27(2):263-4. PubMed ID: 4039120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety of aztreonam and SQ 26,992 in elderly patients with renal insufficiency.
    Sattler FR; Schramm M; Swabb EA
    Rev Infect Dis; 1985; 7 Suppl 4():S622-7. PubMed ID: 4081474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and tissue penetration of azthreonam.
    Wise R; Dyas A; Hegarty A; Andrews JM
    Antimicrob Agents Chemother; 1982 Dec; 22(6):969-71. PubMed ID: 6891575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple-dose pharmacokinetics of ceftazidime in cancer patients.
    Garcia I; Fainstein V; Smith RG; Bodey GP
    Antimicrob Agents Chemother; 1983 Aug; 24(2):141-4. PubMed ID: 6357067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-dose pharmacokinetics of the monobactam azthreonam (SQ 26,776) in healthy subjects.
    Swabb EA; Sugerman AA; Platt TB; Pilkiewicz FG; Frantz M
    Antimicrob Agents Chemother; 1982 Jun; 21(6):944-9. PubMed ID: 7202343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of hemodialysis and peritoneal dialysis on aztreonam pharmacokinetics.
    Gerig JS; Bolton ND; Swabb EA; Scheld WM; Bolton WK
    Kidney Int; 1984 Sep; 26(3):308-18. PubMed ID: 6542606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and plasma bactericidal activity of aztreonam in low-birth-weight infants.
    Likitnukul S; McCracken GH; Threlkeld N; Darabi A; Olsen K
    Antimicrob Agents Chemother; 1987 Jan; 31(1):81-3. PubMed ID: 3105443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral bioavailability of the monobactam aztreonam (SQ 26,776) in healthy subjects.
    Swabb EA; Sugerman AA; Stern M
    Antimicrob Agents Chemother; 1983 Apr; 23(4):548-50. PubMed ID: 6683094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.